Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.

An estimated 440 excess deaths were reported in Los Angeles County during wildfires from Jan 5 to Feb 1, 2025.

Personalized foot angle modifications improved pain, reduced knee loading, and slowed progression of osteoarthritis.

Children with eosinophilic asthma receiving mepolizumab upregulated inflammatory pathways contributing to asthma exacerbations.

Weight-loss interventions before in vitro fertilization were associated with an increase in total pregnancy rates for women with obesity.

As second-line therapy for PsA and axSpA, no clear treatment-retention benefit at 3 years was seen when swapping to a bDMARD with another MOA.

The use of products contaminated with B. cepecia may result in local infections and possibly more serious infections in immunocompromised individuals.